SCHEMBL30537166

SCHEMBL30537166

Cc1ncc(-c2nc(NC3CCN(S(=O)(=O)c4ccn(C)n4)CC3)ncc2C(F)(F)F)s1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 20/20 0.51
▸ CDK2 P24941 20/20 0.51
▸ CDK1 P06493 16/20 0.49
▸ CCNB1 P14635 16/20 0.49
▸ CCND1 P24385 13/20 0.49
▸ CDK6 Q00534 13/20 0.49
▸ CDK4 P11802 12/20 0.49
▸ CCND3 P30281 12/20 0.49
▸ CCNT1 O60563 6/20 0.49
▸ CDK7 P50613 6/20 0.49
▸ CDK9 P50750 6/20 0.49
▸ CCNH P51946 6/20 0.49
▸ MNAT1 P51948 6/20 0.49
▸ CCNB2 O95067 3/20 0.42
▸ CCNE2 O96020 3/20 0.42
▸ CDK5 Q00535 3/20 0.42
▸ CDK5R1 Q15078 3/20 0.42
▸ CCNB3 Q8WWL7 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25402180 1.00 CCNE1 (0.51) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL25401522 0.86 CCNE1 (0.66) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL30537230 0.86 CCNE1 (0.66) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL30537256 0.85 CDK2 (0.67) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL25403549 0.85 CDK2 (0.67) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL25404136 0.84 CCNE1 (0.67) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL30537277 0.84 CCNE1 (0.67) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL25402390 0.83 CCNE1 (0.56) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL25398838 0.83 CCNE1 (0.59) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL30537182 0.83 CCNE1 (0.56) CCNE1CDK2CDK1CCNB1CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023172957-A1 THAIZOLE-PYRIMDIINE CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS, INCORPORATED (US) 2023-09-14 — — WO claimed
WO-2023172957-A1 THAIZOLE-PYRIMDIINE CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS, INCORPORATED (US) 2023-09-14 — — WO disclosed
Send feedback